Regent Pacific's Strategic Partners Submits NDA for Premature Ejaculation Drug in China

MT Newswires Live12-18

Regent Pacific Group's (HKG:0575) commercial strategic partner, Jiangsu Wanbang Biopharmaceutical Group, has submitted a new drug application (NDA) for Senstend to China's National Medical Products Administration, a Wednesday bourse filing said.

Senstend is a proprietary formulation of two marketed drugs, lidocaine and prilocaine, developed for the treatment of premature ejaculation.

Jiangsu Wanbang Biopharmaceutical Group is a wholly-controlled company of Shanghai Fosun Pharmaceutical (SHA:600196, HKG:2196).

Price (HKD): $0.33, Change: $-0.015, Percent Change: -4.35%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2492490424?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-18 19:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492490424","market":"fut","top_or_hot":-1,"title":"Regent Pacific's Strategic Partners Submits NDA for Premature Ejaculation Drug in China","media":"MT Newswires Live","content":"<html><body><p> Regent Pacific Group's (HKG:0575) commercial strategic partner, Jiangsu Wanbang Biopharmaceutical Group, has submitted a new drug application (NDA) for Senstend to China's National Medical Products Administration, a Wednesday bourse filing said.</p><p>Senstend is a proprietary formulation of two marketed drugs, lidocaine and prilocaine, developed for the treatment of premature ejaculation.</p><p>Jiangsu Wanbang Biopharmaceutical Group is a wholly-controlled company of Shanghai Fosun Pharmaceutical (SHA:600196, HKG:2196).</p><p>Price (HKD): $0.33, Change: $-0.015, Percent Change: -4.35%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regent Pacific's Strategic Partners Submits NDA for Premature Ejaculation Drug in China</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegent Pacific's Strategic Partners Submits NDA for Premature Ejaculation Drug in China\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-18 19:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Regent Pacific Group's (HKG:0575) commercial strategic partner, Jiangsu Wanbang Biopharmaceutical Group, has submitted a new drug application (NDA) for Senstend to China's National Medical Products ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02196","symbol_name":"复星医药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2492490424","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492490424","pubTimestamp":1734522466,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Regent Pacific Group's (HKG:0575) commercial strategic partner, Jiangsu Wanbang Biopharmaceutical Group, has submitted a new drug application (NDA) for Senstend to China's National Medical Products Ad","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600196":"复星医药","02196":"复星医药","BK0028":"国家队","HKD":"尚乘数科","BK4526":"热门中概股","BK0188":"融资融券","BK4588":"碎股","BK0187":"一线龙头","BK0239":"医药制造","BK1191":"制药","BK1593":"医美概念股","BK0175":"白马股","BK0183":"MSCI概念","BK0012":"证金概念","BK0196":"行业龙头","BK0096":"民营医院","BK4023":"应用软件","00575":"励晶太平洋","BK0060":"抗癌","BK1515":"抗疫概念","BK4585":"ETF&股票定投概念"},"translate_title":"丽晶太平洋战略合作伙伴在中国提交早泄药物NDA","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600196":0.9,"HKD":1,"02196":0.9,"00575":0.9},"content_text":"Regent Pacific Group's (HKG:0575) commercial strategic partner, Jiangsu Wanbang Biopharmaceutical Group, has submitted a new drug application (NDA) for Senstend to China's National Medical Products Administration, a Wednesday bourse filing said.Senstend is a proprietary formulation of two marketed drugs, lidocaine and prilocaine, developed for the treatment of premature ejaculation.Jiangsu Wanbang Biopharmaceutical Group is a wholly-controlled company of Shanghai Fosun Pharmaceutical (SHA:600196, HKG:2196).Price (HKD): $0.33, Change: $-0.015, Percent Change: -4.35%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492490424"}